- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 388.01M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 240.58M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 3.04M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.69M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $999.82K |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $32.54M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $7.55M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $58.5M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $322.74M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $232.63M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $18.3M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $17.98M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $18.3M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $17.98M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $224.56M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $244.67M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $340.63M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $250.19M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.32 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.84 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.32 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.84 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $10.73M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.23M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$76.14M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.55M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$10.51M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.42M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $215.26K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $813.26K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $7.35M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $9.1M |
| Revenue | Q1 2026 · Mar 31, 2026 | $7.56M |
| Revenue | Q1 2026 · Mar 31, 2025 | $9.91M |
| Capex | Q1 2026 · Mar 31, 2025 | $157 |